PLACEMENT AGENCY AGREEMENT November 13, 2023Placement Agency Agreement • November 15th, 2023 • Mainz Biomed N.V. • Pharmaceutical preparations • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), Mainz Biomed N.V., a public company under Dutch law (the “Company”), hereby agrees to sell up to an aggregate of $5,000,000.40 of securities of the Company, including, but not limited to, ordinary shares (the “Shares” or “Securities”) of the Company, €0.01 par value per Share (the “Ordinary Shares”) and warrants (the “Warrants”) to purchase Ordinary Shares (the “Warrant Shares” and, together with the Shares and the Warrants, the “Securities”) directly to various investors (each, an “Investor” and, collectively, the “Investors”) through Titan Partners Group LLC, a division of American Capital Partners, LLC (together with its affiliates, “Titan Partners” or the “Placement Agent”) as placement agent. The documents executed and delivered by the Company and the Investors in connection with the Offering (as defined below), including, without limitation, securities purchase agreements (the “Purchase Agreements”), sha
Securities PURCHASE AGREEMENTSecurities Purchase Agreement • November 15th, 2023 • Mainz Biomed N.V. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 13, 2023, between Mainz Biomed N.V., a public company under Dutch law (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
